ALL
Pharma?in?China
Pharma?Experts
Market News
Products Guide
Brand Story
-
IGM Biosciences Appoints Chris Takimoto as CMO firstwordpharma
July 30, 2021IGM today announced the appointment of Chris H. Takimoto, M.D., Ph.D., F.A.C.P., to the role of Chief Medical Officer, effective today. Dr. Takimoto will be responsible for global development of IGM's clinical pipeline of proprietary IgM antibodies.
Pharma Sources Insight January 2025
